Home » EMA Outlines Plan to Ensure Quality of Foreign Clinical Trials
EMA Outlines Plan to Ensure Quality of Foreign Clinical Trials
The European Medicines Agency must increase inspections of foreign trials and work with regulators and ethics bodies in other countries to ensure there is a robust framework for the oversight and conduct of clinical trials, a new EMA report concludes. Support to countries with developing or missing regulatory or ethical programs should be a priority, and countries where important or growing numbers of trials are performed should be identified and targeted for limited EU resources, the April 16 reflection paper states.
International Pharmaceutical Regulatory Monitor
International Pharmaceutical Regulatory Monitor
Upcoming Events
-
07May
-
14May
-
30May